Location History:
- Cherry Hinton, GB (2000)
- Zuricu, CH (2014)
- Zurich, CH (2001 - 2021)
- Buchs, CH (2011 - 2021)
- Zürich, CH (2012 - 2022)
Company Filing History:
22 out of 50 
8 out of 16 
4 out of 259 
Years Active: 2000-2022
Areas of Expertise:
Title: Dario Neri: Pioneer in Biomedicine
Introduction
Dario Neri is a renowned inventor based in Buchs, Switzerland, with an impressive portfolio of 40 patents. His contributions to the field of biomedicine, particularly in therapeutic proteins and immunoconjugates, have made significant impacts on medical science and treatments.
Latest Patents
Among his latest innovations, Neri's work on "Vascular endothelial growth factor/anti-fibronectin antibody fusion proteins" stands out. This patent focuses on a fusion protein that combines an antibody molecule with a member of the vascular endothelial growth factor family, specifically VEGF-C or VEGF-D. This therapeutic approach targets inflammatory diseases by binding to antigens associated with angiogenesis, such as the ED-A isoform of fibronectin.
Another notable patent includes "IL2 and TNF mutant immunoconjugates," which involves conjugates that consist of interleukin 2 (IL2) and a mutant of tumor necrosis factor, such as TNF-alpha. This conjugate is designed to bind to antigens associated with neoplastic growth and angiogenesis, offering promising therapeutic applications in cancer treatment.
Career Highlights
Throughout his career, Dario Neri has made significant strides in the field of biomedicine. He has worked with notable companies, including Philogen S.p.a. and the prestigious ETH Zurich (Eidgenoessische Technische Hochschule Zurich). His innovative research and patent contributions continue to push the boundaries of medical advancements.
Collaborations
Neri has collaborated with esteemed colleagues, including Gregory Paul Winter and Barbara Carnemolla. These partnerships have fostered an environment of innovation and excellence in research, driving forward the development of new medical therapies.
Conclusion
Dario Neri's extensive portfolio of patents and his commitment to advancing biomedicine underscores his status as a leading inventor. His latest innovations in therapeutic proteins and immunoconjugates are paving the way for new treatments, particularly in the realms of inflammatory diseases and cancer. Through his collaborations and career achievements, Neri continues to impact the scientific community significantly.